Skip to content

Screener

Eligibility screening

Inotuzumab Ozogamicin in High-Risk B-ALL

Sponsored by Children's Oncology GroupStudy detailsClinicalTrials.gov

203 US sites in AK, AL, AR, AZ +45

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.